Inhibitory effect of conjugated dienoic derivatives of linoleic acid and beta-carotene on the in vitro growth of human cancer cells

Cancer Lett. 1992 Apr 15;63(2):125-33. doi: 10.1016/0304-3835(92)90062-z.

Abstract

The effects of physiologic concentrations of conjugated linoleic acid (CLA) and beta-carotene were assessed on human (M21-HPB, malignant melanoma; HT-29, colorectal; MCF-7, breast) cancer cells. The incubation of cancer cells with CLA showed significant reductions in proliferation (18-100%) compared to control cultures. M21-HPB and MCF-7 cell mortality was dose- and time-dependent. beta-Carotene was inhibitory to breast cells only. MCF-7 cells supplemented with CLA incorporated significantly less [3H]leucine (45%), [3H]uridine (63%) and [3H]thymidine (46%) than control cultures. M21-HPB and HT-29 cells supplemented with CLA incorporated less [3H]leucine (25-30%). These in vitro results suggest that CLA and beta-carotene may be cytotoxic to human cancer cells in vivo.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Breast Neoplasms
  • Carotenoids / analogs & derivatives*
  • Carotenoids / pharmacology*
  • Cell Division / drug effects*
  • Cell Line
  • Colonic Neoplasms
  • DNA, Neoplasm / biosynthesis
  • Dose-Response Relationship, Drug
  • Female
  • Humans
  • Leucine / metabolism
  • Linoleic Acids / pharmacology*
  • Melanoma
  • Neoplasm Proteins / biosynthesis
  • RNA, Neoplasm / biosynthesis
  • Thymidine / metabolism
  • Tritium
  • Tumor Cells, Cultured
  • Uridine / metabolism
  • beta Carotene

Substances

  • DNA, Neoplasm
  • Linoleic Acids
  • Neoplasm Proteins
  • RNA, Neoplasm
  • beta Carotene
  • Tritium
  • Carotenoids
  • Leucine
  • Thymidine
  • Uridine